Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
S-337395 in Symptomatic Nonhospitalized Adults With RSV at High Risk of Progression
NCT07214571Phase 2Recruiting
- Sponsor
- Shionogi & Co., Ltd.
- Start
- Dec 2025
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of S-337395 in respiratory syncytial virus infection (RSV), sponsored by Shionogi & Co., Ltd.. Started Dec 2025; status: recruiting.
02
Drugs
S-337395
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT07214571.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07214571.